T1	p 44 75	children with acute diarrhoea .
T2	p 192 207	acute childhood
T3	p 333 364	children with acute diarrhoea .
T4	p 373 398	Two hundred children were
T5	p 537 541	5 d.
T6	p 586 595	admission
T7	p 1554 1562	children
T8	i 17 40	Saccharomyces boulardii
T9	i 113 129	Lactobacillus GG
T10	i 264 289	Saccharomyces boulardii .
T11	i 317 329	S. boulardii
T12	i 421 454	S. boulardii in a granulated form
T13	i 474 530	250 mg ( S. boulardii group ) or placebo ( placebo group
T14	i 760 769	boulardii
T15	i 788 795	placebo
T16	i 876 885	boulardii
T17	i 910 917	placebo
T18	i 968 980	S. boulardii
T19	i 1109 1118	boulardii
T20	i 1137 1144	placebo
T21	i 1205 1212	placebo
T22	i 1253 1262	boulardii
T23	i 1311 1329	placebo-controlled
T24	i 1351 1363	S. boulardii
T25	i 1457 1466	boulardii
T26	o 143 151	efficacy
T27	o 648 655	medians
T28	o 663 686	average stool frequency
T29	o 822 857	duration of diarrhoea significantly
T30	o 968 1007	S. boulardii on watery diarrhoea became
T31	o 1061 1086	duration of hospital stay
T32	o 1273 1295	persisting diarrhoea .
T33	o 1390 1417	duration of acute diarrhoea
T34	o 1426 1453	duration of hospital stay .
T35	o 1535 1550	acute diarrhoea